Asthma Treatments: Effects on the Airway Smooth Muscle

Airway Smooth Muscle in Asthma and COPD: Biology and Pharmacology

Volumn , Issue , 2008, Pages 277-302

  Chung, Kian Fan ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

2 adrenergic agonists; Airways disease ASM biology; ASM cell corticosteroid resistance in vitro; Asthma and COPD airway smooth muscle (ASM); Bronchial thermoplasty technique; Corticosteroid and ASM hyperplasia control; Leukotriene receptor antagonists; Mild asthma treatment; Theophylline and phosphodiesterase inhibitors

Indexed keywords

EID: 84875658366     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470754221.ch14     Document Type: Chapter

References (133)

1. Alagappan, V. K., McKay, S., Widyastuti, A. et al. (2005). Proinflammatory cytokines upregulate mRNA expression and secretion of vascular endothelial growth factor in cultured human airway smooth muscle cells. Cell Biochem Biophys 43, 119-129.
2. Alagappan, V. K., Willems-Widyastuti, A., Seynhaeve, A. L. et al. (2007). Vasoactive peptides upregulate mRNA expression and secretion of vascular endothelial growth factor in human airway smooth muscle cells. Cell Biochem Biophys 47, 109-118.
3. Ammit, A. J., Hoffman, R. K., Amrani, Y. et al. (2000). Tumor necrosis factor-alphainduced secretion of RANTES and interleukin-6 from human airway smooth-muscle cells. Modulation by cyclic adenosine monophosphate. Am J Respir Cell Mol Biol 23, 794-802.
4. Ammit, A. J., Lazaar, A. L., Irani, C. et al. (2002). Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am J Respir Cell Mol Biol 26, 465-474.
5. Amrani, Y., Lazaar, A. L., Panettieri, R. A. J. (1999). Up-regulation of ICAM-1 by cytokines in human tracheal smooth muscle cells involves an NF-kappaB-dependent signaling pathway that is only partially sensitive to dexamethasone. J Immunol 163, 2128-2134.
6. An, S. S., Bai, T. R., Bates, J. H. et al. (2007). Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J 29, 834-860.
7. Bai, T. R. (1990). Abnormalities in airway smooth muscle in fatal asthma. Am Rev Respir Dis 141, 552-557.
8. Bai, T. R., Mak, J. C.W. and Barnes, P. J. (1992). A comparison of β-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle. Am J Respir Cell Mol Biol 6, 647-651.
9. Barnes, P. J. (2005).Theophylline in chronic obstructive pulmonary disease: newhorizons. Proc Am Thorac Soc 2, 334-339.
10. Belvisi, M. G., Saunders, M. A., Haddad, el-B. et al. (1997). Induction of cyclooxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br J Pharmacol 120, 910-916.
11. Benayoun, L., Druilhe, A., Dombret, M. C. et al. (2003). Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 167, 1360-1368.
12. Berkman, N., Krishnan, V. L., Gilbey, T. et al. (1996). Expression of RANTES mRNA and protein in airways of patients with mild asthma. Am J Respir Crit Care Med 154, 1804-1811.
13. Berry,M. A., Hargadon, B., Shelley, M. et al. (2006). Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 354, 697-708.
14. Bonacci, J. V., Schuliga, M., Harris, T. et al. (2006). Collagen impairs glucocorticoid actions in airway smooth muscle through integrin signalling. Br J Pharmacol 149, 365-373.
15. Bonacci, J. V. and Stewart, A. G. (2006). Regulation of human airway mesenchymal cell proliferation by glucocorticoids and beta2-adrenoceptor agonists. Pulm Pharmacol Ther 19, 32-38.
16. Bradding, P., Roberts, J. A., Britten, K. M. et al. (1994). Interleukin-4,-5 and-6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 10, 471-480.
17. Brightling, C. E., Ammit, A. J., Kaur,D. et al. (2005). The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 171, 1103-1108.
18. Brightling, C. E., Bradding, P., Symon, F. A. et al. (2002). Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 346, 1699-1705.
19. Brown, R. H., Zerhouni, E. A. and Mitzner,W. (1995). Airway edema potentiates airway reactivity. J Appl Physiol 79, 1242-1248.
20. Burgess, J. K., Carlin, S., Pack, R. A. et al (2004). Detection and characterization ofOX40 ligand expression in human airway smooth muscle cells: a possible role in asthma? J Allergy Clin Immunol, 113, 683-689.
21. Burgess, J. K., Johnson, P. R., Ge, Q. et al. (2003). Expression of connective tissue growth factor in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med 167, 71-77.
22. Burgess, J. K., Oliver, B. G., Poniris, M. H. et al. (2006). A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro. J Allergy Clin Immunol 118, 649-657.
23. Busse, W., Corren, J., Lanier, B. Q. et al. (2001). Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 108, 184-190.
24. Cerrina, J., Ladurie, M. L., Lebat, G. et al. (1986). Comparison of human bronchial muscle response to histamine in vivo with histamine and isoproterenol agonists in vitro. Am Rev Respir Dis 134, 57-61.
25. Chan,V., Burgess, J. K., Ratoff, J. C. et al. (2006). Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. Am J Respir Crit Care Med 174, 379-385.
26. Chung, K. F (2000). Airway smooth muscle cells: contributing to and regulating airway mucosal inflammation? Eur Respir J, 15, 961-968.
27. Chung, K. F. (2006). Phosphodiesterase inhibitors in airways disease. Eur J Pharmacol 533, 110-117.
28. Chung, K. F., Patel, H. J., Fadlon, E. J. et al. (1999). Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1beta and TNFalpha: effects of IL-10 and corticosteroids. Br J Pharmacol 127, 1145-1150.
29. Cox, G., Miller, J. D., McWilliams, A. et al. (2006). Bronchial thermoplasty for asthma. Am J Respir Crit Care Med 173, 965-969.
30. Cox, G., Thomson, N. C., Rubin, A. S. et al. (2007). Asthma control during the year after bronchial thermoplasty. N Engl J Med 356, 1327-1337.
31. DeJongste, J. C., Mons, H., Bonta, I. L. et al. (1987). In vitro responses of airways from an asthmatic patient. Eur J Respir Dis 71, 23-29.
32. Deshpande, D. A.,Walseth, T. F., Panettieri, R. A. et al. (2003). CD38/cyclic ADP-ribosemediated Ca2+ signaling contributes to airway smooth muscle hyper-responsiveness. FASEB J 17, 452-454.
33. Djukanovic, R., Wilson, S. J., Kraft, M. et al. (2004).The effects of anti-IgE (omalizumab) on airways inflammation in allergic asthma. Am J Respir Crit Care Med 170, 583-593.
34. Ebina, M., Takahashi, T., Chiba, T. et al. (1993). Cellular hypertrophy and hyperplasia of airway smooth muscle underlying bronchial asthma. Am Rev Respir Dis 148, 720-726.
35. Elshaw, S. R., Henderson, N., Knox, A. J. et al. (2004). Matrix metalloproteinase expression and activity in human airway smooth muscle cells. Br J Pharmacol 142, 1318-1324.
36. Erin, E. M., Leaker, B. R., Nicholson, G. C. et al. (2006). The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma. Am J Respir Crit Care Med 174, 753-762.
37. Espinosa, K., Bosse, Y., Stankova, J. et al. (2003). CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol 111, 1032-1040.
38. Evans, D. J., Taylor,D. A., Zetterstrom, O. et al. (1997).Acomparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 337, 1412-1418.
39. Faffe, D. S., Flynt, L., Bourgeois, K. et al. (2006). Interleukin-13 and interleukin-4 induce vascular endothelial growth factor release from airway smooth muscle cells: role of vascular endothelial growth factor genotype. Am J Respir Cell Mol Biol 34, 213-218.
40. Fernandes, D., Guida, E., Koutsoubos, V. et al. (1999). Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. Am J Respir Cell Mol Biol 21, 77-88.
41. Flood-Page, P., Menzies-Gow, A., Phipps, S. et al. (2003). Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 112, 1029-1036.
42. Foley, S. C., Mogas, A. K., Olivenstein, R. et al. (2007). Increased expression ofADAM33 andADAM8with disease progression in asthma. J Allergy Clin Immunol 119, 863-871.
43. Fredberg, J. J. (2007). Counterpoint: airway smooth muscle is not useful. J Appl Physiol 102,1709-1710.
44. Freyer, A. M., Billington, C. K., Penn, R. B. et al. (2004). Extracellular matrix modulates {beta}2-adrenergic receptor signaling in human airway smooth muscle cells. Am J Respir Cell Mol Biol 31, 440-445.
45. Freyer, A. M., Johnson, S. R. and Hall, I. P. (2001). Effects of growth factors and extracellular matrix on survival of human airway smooth muscle cells. Am J Respir Cell Mol Biol 25, 569-576.
46. Ghaffar, O., Hamid, Q., Renzi, P. M. et al. (1999). Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells. Am J Respir Crit Care Med 159, 1933-1942.
47. Goldsmith, A. M., Bentley, J. K., Zhou, L. et al. (2006). Transforming growth factorbeta induces airway smooth muscle hypertrophy. Am J Respir Cell Mol Biol 34, 247-254.
48. Goldsmith, A. M., Hershenson, M. B., Wolbert, M. P. et al. (2007). Regulation of airway smooth muscle alpha-actin expression by glucocorticoids. Am J Physiol Lung Cell Mol Physiol 292, L99-L106.
49. Goncharova, E. A., Billington, C. K., Irani, C. et al. (2003). Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration. Am J Respir Cell Mol Biol 29, 19-27.
50. Gounni, A. S. (2006). The high-affinity IgE receptor (FcepsilonRI): a critical regulator of airway smooth muscle cells? Am J Physiol Lung Cell Mol Physiol 291, L312-L321.
51. Gounni, A. S., Wellemans, V., Yang, J. et al. (2005). Human airway smooth muscle cells express the high affinity receptor for IgE (Fc epsilon RI): a critical role of Fc epsilon RI in human airway smooth muscle cell function. J Immunol 175, 2613-2621.
52. Govindaraju, V., Michoud, M. C., Al Chalabi, M. et al. (2006). Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration. Am J Physiol Cell Physiol 291, C957-C965.
53. Hallsworth, M. P., Twort, C. H., Lee, T. H. et al. (2001). beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells. Br J Pharmacol 132, 729-741.
54. Hardy, E., Farahani, M. and Hall, I. P. (1996). Regulation of histamineH1receptor coupling by dexamethasone in human cultured airway smooth muscle. Br J Pharmacol 118, 1079-1084.
55. Hardaker, E. L., Bacon, A. M., Carlson, K. et al. (2004). Regulation of TNF-alpha-and IFN-gamma-induced CXCL10 expression: participation of the airway smooth muscle in the pulmonary inflammatory response in chronic obstructive pulmonary disease. FASEB J 18, 191-193.
56. Henderson, W. R., Jr., Chiang, G. K., Tien, Y. T. et al. (2006). Reversal of allergeninduced airway remodeling by CysLT1 receptor blockade. Am J Respir Crit Care Med 173, 718-728.
57. Hew, M., Bhavsar, P., Torrego, A. et al. (2006). Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 174, 134-141.
58. Hirst, S. J. and Lee, T. H. (1998). Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma. Am J Respir Crit Care Med 158, S201-S206.
59. Hirst, S. J., Twort, C. H. and Lee, T. H. (2000). Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype. AmJ Respir Cell Mol Biol 23, 335-344.
60. Hirst, S. J., Walker, T. R. and Chilvers, E. R. (2000). Phenotypic diversity and molecular mechanisms of airway smooth muscle proliferation in asthma. Eur Respir J 16, 159-177.
61. Howarth, P. H., Babu, K. S., Arshad, H. S. et al. (2005). Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 60, 1012-1018.
62. Huang, C. D., Tliba, O., Panettieri, R. A., Jr. et al. (2003). Bradykinin induces interleukin-6 production in human airway smooth muscle cells: modulation by Th2 cytokines and dexamethasone. Am J Respir Cell Mol Biol 28, 330-338.
63. Hui, K. P. and Barnes, N. C. (1991). Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist. Lancet 337, 1062-1063.
64. Ibe, B. O., Portugal, A. M. and Raj, J. U. (2006). Levalbuterol inhibits human airway smooth muscle cell proliferation: therapeutic implications in the management of asthma. Int Arch Allergy Immunol 139, 225-236.
65. Issa, R., Xie, S., Khorasani, N. et al. (2007). Corticosteroid inhibition of growthrelated oncogene protein-{alpha} via mitogen-activated kinase phosphatase-1 in airway smooth muscle cells. J Immunol 178, 7366-7375.
66. Issa, R., Xie, S., Lee, K.Y. et al. (2006).GRO-{alpha} regulation in airway smooth muscle by IL-1beta and TNF-{alpha}: role of NF-{kappa}B and MAP kinases. Am J Physiol Lung Cell Mol Physiol 291, L66-L74.
67. James, A. L., Pare, P. D. and Hogg, J. C. (1989). The mechanics of airway narrowing in asthma. Am Rev Respir Dis 139, 242-246. 26.
68. Janssen, L. J., Tazzeo, T. and Zuo, J. (2004). Enhanced myosin phosphatase and Ca(2+)-uptake mediate adrenergic relaxation of airway smooth muscle. Am J Respir Cell Mol Biol 30, 548-554.
69. Jarai, G., Sukkar, M., Garrett, S. et al. (2004). Effects of interleukin-1beta, interleukin-13 and transforming growth factor-beta on gene expression in human airway smooth muscle using gene microarrays. Eur J Pharmacol 497, 255-265.
70. John, M., Au, B. T., Jose, P. J. et al. (1998). Expression and release of interleukin-8 by human airway smooth muscle cells: inhibition by Th-2 cytokines and corticosteroids. Am J Respir Cell Mol Biol 18, 84-90.
71. John, M., Hirst, S. J., Jose, P. J. et al. (1997). Human airway smooth muscle cells express and release RANTES in response to Th-1 cytokines: regulation by Th-2 cytokines and corticosteroids. J Immunol 158, 1841-1847.
72. Johnson, P. R., Black, J. L., Carlin, S., et al. (2000). The production of extracellular matrix proteins by human passively sensitized airway smooth-muscle cells in culture: the effect of beclomethasone. Am J Respir Crit Care Med 162, 2145-2151.
73. Johnson, P. R., Burgess, J. K, Underwood, P. A. et al. (2004). Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism. J Allergy Clin Immunol 113, 690-696.
74. Johnson, P. R., Roth, M., Tamm, M. et al. (2001). Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 164, 474-477.
75. Kamm, K. E. and Stull, J. T. (1985). The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25, 593-620.
76. Kang, B. N., Tirumurugaan, K. G., Deshpande, D. A. et al. (2006). Transcriptional regulation of CD38 expression by tumor necrosis factor-alpha in human airway smooth muscle cells: role of NF-kappaB and sensitivity to glucocorticoids. FASEB J 20, 1000-1002.
77. Kassel, O., Schmidlin, F., Duvernelle, C. et al. (1999). Human bronchial smooth muscle cells in culture produce stem cell factor. Eur Respir J 13, 951-954.
78. Kips, J. C., O'Connor, B. J., Langley, S. J. et al. (2003). Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med 167, 1655-1659.
79. Kotlikoff, M. I. and Kamm, K. E. (1996). Molecular mechanisms of beta-adrenergic relaxation of airway smooth muscle. Annu Rev Physiol 58, 115-141.
80. Koto, H., Mak, J. C., Haddad, E. B. et al. (1996). Mechanisms of impaired betaadrenoceptor-induced airway relaxation by interleukin-1beta in vivo in the rat. J Clin Invest 98, 1780-1787.
81. Lazaar, A. L., Albelda, S. M., Pilewski, J. M. et al. (1994). T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. J Exp Med 180, 807-816.
82. Lazzeri, N., Belvisi, M. G., Patel, H. J. et al. (2001). RANTES release by human airway smooth muscle: effects of prostaglandin E(2) and fenoterol. Eur J Pharmacol 433, 231-235.
83. Leckie, M. J., ten Brinke, A., Khan, J. et al. (2000). Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356(9248), 2114-2116.
84. Leung, S. Y., Eynott, P., Nath, P. et al. (2005). Effects of ciclesonide and fluticasone propionate on allergen-induced airway inflammation and remodeling features. J Allergy Clin Immunol 115, 989-996.
85. Leung, S. Y., Niimi, A., Noble, A. et al. (2006). Effect of transforming growth factorbeta receptor I kinase inhibitor 2,4-disubstituted pteridine (SD-208) in chronic allergic airway inflammation and remodeling. J Pharmacol Exp Ther 319, 586-594.
86. Liu, C., Zuo, J. and Janssen, L. J. (2006). Regulation of airway smooth muscle RhoA/ROCK activities by cholinergic and bronchodilator stimuli. Eur Respir J 28, 703-711.
87. Lu, D., Xie, S., Sukkar, M. B. et al. (2007). Inhibition of airway smooth muscle adhesion and migration by the disintegrin domain of ADAM-15. Am J Respir Cell Mol Biol 37, 494-500.
88. Ma, X., Cheng, Z., Kong, H. et al. (2002). Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. Am J Physiol Lung Cell Mol Physiol 283, L1181-L1189.
89. Ma, X., Wang, Y. and Stephens, N. L. (1998). Serum deprivation induces a unique hypercontractile phenotype of cultured smooth muscle cells. Am J Physiol 274, C1206-C1214.
90. Mak, J. C., Hisada, T., Salmon, M. et al. (2002). Glucocorticoids reverse IL-1beta-induced impairment of beta-adrenoceptor-mediated relaxation and up-regulation of G-proteincoupled receptor kinases. Br J Pharmacol 135, 987-996.
91. Matsumoto, H., Moir, L. M., Oliver, B. G. et al. (2007). Comparison of gel contraction mediated by asthmatic and non-asthmatic airway smooth muscle cells. Thorax 62, 848-854.
92. McVicker, C. G., Leung, S. Y., Kanabar, V. et al. (2007). Repeated allergen inhalation induces cytoskeletal remodeling in smooth muscle from rat bronchioles. Am J Respir Cell Mol Biol 36, 721-727.
93. Miller, J. D., Cox, G., Vincic, L. et al. (2005). A prospective feasibility study of bronchial thermoplasty in the human airway. Chest 127, 1999-2006.
94. Mitzner, W. (2004). Airway smooth muscle: the appendix of the lung. Am J Respir Crit Care Med 169, 787-790.
95. Moir, L. M., Leung, S. Y., Eynott, P. R. et al. (2003). Repeated allergen inhalation induces phenotypic modulation of smooth muscle in bronchioles of sensitized rats. AmJ Physiol Lung Cell Mol Physiol 284, L148-L159.
96. Moore, P. E., Laporte, J. D., Gonzalez, S. et al. (1999). Glucocorticoids ablate IL-1betainduced beta-adrenergic hyporesponsiveness in human airway smooth muscle cells. Am J Physiol 277, L932-L942.
97. Morris, G. E., Parker, L. C., Ward, J. R. et al. (2006). Cooperative molecular and cellular networks regulate Toll-like receptor-dependent inflammatory responses. FASEB J 20, 2153-2155.
98. Nie, M., Corbett, L., Knox, A. J. et al. (2005). Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists. J Biol Chem 280, 2550-2561.
99. Nie, M., Knox, A. J. and Pang, L. (2005). beta2-Adrenoceptor agonists, like glucocorticoids, repress eotaxin gene transcription by selective inhibition of histone H4 acetylation. J Immunol 175, 478-486.
100. Oltmanns, U., Walters, M., Sukkar, M. et al. (2007). Fluticasone, but not salmeterol, reduces cigarette smoke-induced production of interleukin-8 in human airway smooth muscle. Pulm Pharmacol Ther (in press).
101. Panettieri, R. A., Tan, E. M., Ciocca, V. et al. (1998). Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction in vitro: differential sensitivity to cysteinyl leukotriene receptor antagonists. Am J Respir Cell Mol Biol 19, 453-461.
102. Pang, L. and Knox, A. J. (2000). Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells. Am J Respir Cell Mol Biol 23, 79-85.
103. Pang, L. and Knox, A. J. (2001). Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids. FASEB J 15, 261-269.
104. Parameswaran, K., Cox, G., Radford, K. et al. (2002). Cysteinyl leukotrienes promote human airway smooth muscle migration. Am J Respir Crit Care Med 166, 738-742.
105. Peachell, P. (2006). Regulation of mast cells by beta-agonists. Clin Rev Allergy Immunol 31, 131-142.
106. Pennings, H. J., Kramer, K., Bast, A. et al. (1998). Tumour necrosis factor-alpha induces hyperreactivity in tracheal smooth muscle of the guinea-pig in vitro. Eur Respir J 12, 45-49.
107. Pepe, C., Foley, S., Shannon, J. et al. (2005). Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol 116, 544-549.
108. Pype, J. L., Dupont, L. J., Menten, P. et al. (1999). Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells. Modulation by corticosteroids and T-helper 2 cytokines. Am J Respir Cell Mol Biol 21, 528-536.
109. Roth, M., Johnson, P. R., Borger, P. et al. (2004). Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N Engl J Med 351, 560-574.
110. Roth, M., Johnson, P. R., Rudiger, J. J. et al. (2002). Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet 360, 1293-1299.
111. Salmon, M.,Walsh, D. A., Huang, T. J. et al. (1999). Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized brown Norway rats. Br J Pharmacol 127, 1151-1158.
112. Saunders, M. A., Mitchell, J. A., Seldon, P. M. et al. (1997). Release of granulocytemacrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone. Br J Pharmacol 120, 545-546.
113. Skloot, G. and Togias, A. (2003). Bronchodilation and bronchoprotection by deep inspiration and their relationship to bronchial hyperresponsiveness. Clin Rev Allergy Immunol 24, 55-72.
114. Slats, A. M., Sont, J. K., van Klink, R. H. et al. (2006). Improvement in bronchodilation following deep inspiration after a course of high-dose oral prednisone in asthma. Chest 130, 58-65.
115. Soler, M., Matz, J., Townley, R. et al. (2001). The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. Eur Respir J 18, 254-261.
116. Stewart, A. G., Harris, T., Fernandes, D. J. et al. (1999). Beta2-adrenergic receptor agonists and cAMP arrest human cultured airway smooth muscle cells in the G(1) phase of the cell cycle: role of proteasome degradation of cyclin D1. Mol Pharmacol 56, 1079-1086.
117. Stewart, A. G., Tomlinson, P. R. and Wilson, J. W. (1997). Beta 2-adrenoceptor agonistmediated inhibition of human airway smooth muscle cell proliferation: importance of the duration of beta 2-adrenoceptor stimulation. Br J Pharmacol 121, 361-368.
118. Stocks, J., Bradbury, D., Corbett, L. et al. (2005). Cytokines upregulate vascular endothelial growth factor secretion by human airway smooth muscle cells: role of endogenous prostanoids. FEBS Lett 579, 2551-2556.
119. Sukkar, M. B., Hughes, J. M., Armour, C. L. et al. (2001). Tumour necrosis factor-alpha potentiates contraction of human bronchus in vitro. Respirology 6, 199-203.
120. Sukkar, M. B., Issa, R., Xie, S. et al. (2004). Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-gamma and TNF-alpha and regulation by TGF-beta and corticosteroids. Am J Physiol Lung Cell Mol Physiol 287, L1230-L1240.
121. Sukkar, M. B., Xie, S., Khorasani, N. M. et al. (2006). Toll-like receptor 2, 3, and 4 expression and function in human airway smooth muscle. J Allergy Clin Immunol 118, 641-648.
122. Tanaka, H., Watanabe, K., Tamaru, N. et al. (1995). Arachidonic acid metabolites and glucocorticoid regulatory mechanism in cultured porcine tracheal smooth muscle cells. Lung 173, 347-361.
123. Thomas, P. S. and Heywood, G. (2002). Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma. Thorax 57, 774-778.
124. Thomas, P. S., Yates, D. H. and Barnes, P. J. (1995). Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 152, 76-80.
125. Tliba, O., Cidlowski, J. A. and Amrani, Y. (2006). CD38 expression is insensitive to steroid action in cells treated with tumor necrosis factor-alpha and interferon-gamma by a mechanism involving the up-regulation of the glucocorticoid receptor beta isoform. Mol Pharmacol 69, 588-596.
126. Tomlinson, P. R.,Wilson, J.W. and Stewart, A. G. (1995). Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: relationship to elevated cAMP levels. Biochem Pharmacol 49, 1809-1819.
127. Usmani, O. S., Ito, K., Maneechotesuwan, K. et al. (2005). Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy. Am J Respir Crit Care Med 172, 704-712.
128. Vlahos, R. and Stewart, A. G. (1999). Interleukin-1alpha and tumour necrosis factor-alpha modulate airway smooth muscle DNA synthesis by induction of cyclo-oxygenase-2: inhibition by dexamethasone and fluticasone propionate. Br J Pharmacol 126, 1315-1324.
129. Wang, C. G., Du, T., Xu, L. J. et al. (1993). Role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat. Am Rev Respir Dis 148, 413-417.
130. Woodruff, P. G., Dolganov, G. M., Ferrando, R. E. et al. (2004). Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med 169, 1001-1006.
131. Xie, S., Issa, R., Sukkar, M. B. et al. (2005). Induction and regulation of matrix metalloproteinase-12 in human airway smooth muscle cells. Respir Res 6, 148.
132. Xie, S., Sukkar,M. B., Issa, R. et al. (2005). Regulation of TGF-beta 1-induced connective tissue growth factor expression in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 288, L68-L76.
133. Xie, S., Sukkar, M. B., Issa, R. et al. (2007). Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-beta. Am J Physiol Lung Cell Mol Physiol 293, L245-L253.